Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

Graphite Bio, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Appointed a new director
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 8-K Quarterly results
06/06/2023 ARS Form ARS - Annual Report to Security Holders:
06/06/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/06/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/20/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/20/2023 10-K Annual Report for the period ended December 31, 2022
03/20/2023 8-K Quarterly results
03/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/23/2023 4 Young Alethia (CFO) has filed a Form 4 on Graphite Bio, Inc.
Txns: Granted 220,000 options to buy @ $2.18, valued at $479.6k
02/23/2023 4 Lehrer-Graiwer Joshua (PRESIDENT AND CEO) has filed a Form 4 on Graphite Bio, Inc.
Txns: Granted 600,000 options to buy @ $2.18, valued at $1.3M
02/22/2023 8-K Quarterly results
02/14/2023 SC 13G/A Samsara BioCapital, L.P. reports a 14.6% stake in Graphite Bio, Inc.
01/09/2023 SC 13G/A EcoR1 Capital, LLC reports a 14.7% stake in Graphite Bio, Inc.
01/06/2023 3 EcoR1 Capital, LLC (10% Owner) has filed a Form 3 on Graphite Bio, Inc.
01/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel for Sickle Cell Disease"
12/12/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
11/18/2022 SC 13G EcoR1 Capital, LLC reports a 9.8% stake in Graphite Bio, Inc.
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy